$0.6480
-0.00700-1.07%
Pre-Market: 6:53 AM EDT
Comments
Loading...
Citius Oncology Stock Guidance | NASDAQ:CTOR | Benzinga
Citius Oncology issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citius Oncology Inc (CTOR) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Citius Oncology (CTOR)?
There have been no specific sales or earnings guidance reported for Citius Oncology in recent months.
Browse guidance and forecast on all stocks.